141 related articles for article (PubMed ID: 7069864)
1. Growth and cell survival following treatment with estramustine nor-nitrogen mustard, estradiol and testosterone of a human prostatic cancer cell line (DU 145).
Hartley-Asp B; Gunnarsson PO
J Urol; 1982 Apr; 127(4):818-22. PubMed ID: 7069864
[TBL] [Abstract][Full Text] [Related]
2. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
[TBL] [Abstract][Full Text] [Related]
3. Effects of estramustine and its constituents on human malignant glioma cells.
von Schoultz E; Lundgren E; Henriksson R
Anticancer Res; 1990; 10(3):693-6. PubMed ID: 2369085
[TBL] [Abstract][Full Text] [Related]
4. Antiinvasive activity of estramustine on malignant MO4 mouse cells and on DU-145 human prostate carcinoma cells in vitro.
Mareel MM; Storme GA; Dragonetti CH; De Bruyne GK; Hartley-Asp B; Segers JL; Rabaey ML
Cancer Res; 1988 Apr; 48(7):1842-9. PubMed ID: 3349462
[TBL] [Abstract][Full Text] [Related]
5. Testosterone-induced DNA synthesis in cultured rat ventral prostate: effects of estracyt and its derivatives.
Buchanan LJ; Riches AC
Br J Cancer; 1987 Jan; 55(1):47-51. PubMed ID: 3814475
[TBL] [Abstract][Full Text] [Related]
6. Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3.
Hartley-Asp B
Prostate; 1984; 5(1):93-100. PubMed ID: 6694918
[TBL] [Abstract][Full Text] [Related]
7. Nuclear protein matrix as a target for estramustine-induced cell death.
Hartley-Asp B; Kruse E
Prostate; 1986; 9(4):387-95. PubMed ID: 3786258
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibiting effect of estramustine on two prostatic carcinoma cell lines, LNCaP and LNCaP-r.
Hansenson M; Lundh B; Hartley-Asp B; Pousette A
Urol Res; 1988; 16(5):357-61. PubMed ID: 3201650
[TBL] [Abstract][Full Text] [Related]
9. The effect of estramustine, nor-nitrogen mustard and tauromustine on macromolecular labelling in the human prostatic tumour cell line 1013L.
Kruse E; Hartley-Asp B
Pharmacol Toxicol; 1989 Jan; 64(1):9-13. PubMed ID: 2755916
[TBL] [Abstract][Full Text] [Related]
10. Antimicrotubule effects of estramustine, an antiprostatic tumor drug.
Stearns ME; Tew KD
Cancer Res; 1985 Aug; 45(8):3891-7. PubMed ID: 4016756
[TBL] [Abstract][Full Text] [Related]
11. A study on the effects of estradiol and estramustine on gastrointestinal cell lines.
Harrison JD; Watson S; Ellis IO; Morris DL
Eur J Surg Oncol; 1990 Apr; 16(2):116-20. PubMed ID: 2182340
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targets.
Tew KD; Erickson LC; White G; Wang AL; Schein PS; Hartley-Asp B
Mol Pharmacol; 1983 Sep; 24(2):324-8. PubMed ID: 6888373
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans.
Nilsson I; Liskowski L; Nilsson T
Urology; 1976 Aug; 8(2):118-21. PubMed ID: 60819
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of action of estramustine.
Tew KD
Semin Oncol; 1983 Sep; 10(3 Suppl 3):21-6. PubMed ID: 6364362
[No Abstract] [Full Text] [Related]
15. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
Yamanaka H; Shida K
Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
[TBL] [Abstract][Full Text] [Related]
16. Hormone-independent, non-alkylating mechanism of cytotoxicity for estramustine.
Tew KD; Stearns ME
Urol Res; 1987; 15(3):155-60. PubMed ID: 3307087
[TBL] [Abstract][Full Text] [Related]
17. Estramustine inhibits monocyte phagocytosis.
Bjermer L; von Schoultz E; Norberg B; Henriksson R
Prostate; 1988; 13(1):49-55. PubMed ID: 3047717
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy of advanced prostatic carcinoma with estramustine and prednimustine.
Catane R; Kaufman J; Mittelman A; Murphy GP
J Urol; 1977 Mar; 117(3):332-5. PubMed ID: 839597
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of cyproterone acetate and estramustine phosphate on the plasma levels of testosterone and gonadotrophic hormones in adenocarcinoma of the prostate].
Alfonso Sánchez M; Pérez Herrero F; Urrutia Avisrror M; Vega Wong J; Lago Montero A
Actas Urol Esp; 1986; 10(2):111-6. PubMed ID: 2942009
[No Abstract] [Full Text] [Related]
20. Growth of prostatic cancer cells, DU 145, as multicellular spheroids and effects of estramustine.
Essand M; Nilsson S; Carlsson J
Anticancer Res; 1993; 13(5A):1261-8. PubMed ID: 8239495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
